Patient 7 was diagnosed with early stage breast cancer (initial sample), received neoadjuvant chemotherapy and HER2-targeted therapy which was followed by surgery and trastuzumab and two years after the completion of these therapy she developed a local recurrence (second sample). The gene discussed is ERBB2; the disease is breast carcinoma.